Cargando…
Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge
Abuse of androgens and erythropoietin has led to hormones being the most effective and frequent class of ergogenic substances prohibited in elite sports by the World Anti-Doping Agency (WADA). At present, thyroid hormone (TH) abuse is not prohibited, but its prevalence among elite athletes and nonpr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387720/ https://www.ncbi.nlm.nih.gov/pubmed/35438767 http://dx.doi.org/10.1210/clinem/dgac223 |
_version_ | 1784770070051815424 |
---|---|
author | Gild, Matti L Stuart, Mark Clifton-Bligh, Roderick J Kinahan, Audrey Handelsman, David J |
author_facet | Gild, Matti L Stuart, Mark Clifton-Bligh, Roderick J Kinahan, Audrey Handelsman, David J |
author_sort | Gild, Matti L |
collection | PubMed |
description | Abuse of androgens and erythropoietin has led to hormones being the most effective and frequent class of ergogenic substances prohibited in elite sports by the World Anti-Doping Agency (WADA). At present, thyroid hormone (TH) abuse is not prohibited, but its prevalence among elite athletes and nonprohibited status remains controversial. A corollary of prohibiting hormones for elite sports is that endocrinologists must be aware of a professional athlete’s risk of disqualification for using prohibited hormones and/or to certify Therapeutic Use Exemptions, which allow individual athletes to use prohibited substances for valid medical indications. This narrative review considers the status of TH within the framework of the WADA Code criteria for prohibiting substances, which requires meeting 2 of 3 equally important criteria of potential performance enhancement, harmfulness to health, and violation of the spirit of sport. In considering the valid clinical uses of TH, the prevalence of TH use among young adults, the reason why some athletes seek to use TH, and the pathophysiology of sought-after and adverse effects of TH abuse, together with the challenges of detecting TH abuse, it can be concluded that, on the basis of present data, prohibition of TH in elite sport is neither justified nor feasible. |
format | Online Article Text |
id | pubmed-9387720 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-93877202022-08-19 Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge Gild, Matti L Stuart, Mark Clifton-Bligh, Roderick J Kinahan, Audrey Handelsman, David J J Clin Endocrinol Metab Online Only Articles Abuse of androgens and erythropoietin has led to hormones being the most effective and frequent class of ergogenic substances prohibited in elite sports by the World Anti-Doping Agency (WADA). At present, thyroid hormone (TH) abuse is not prohibited, but its prevalence among elite athletes and nonprohibited status remains controversial. A corollary of prohibiting hormones for elite sports is that endocrinologists must be aware of a professional athlete’s risk of disqualification for using prohibited hormones and/or to certify Therapeutic Use Exemptions, which allow individual athletes to use prohibited substances for valid medical indications. This narrative review considers the status of TH within the framework of the WADA Code criteria for prohibiting substances, which requires meeting 2 of 3 equally important criteria of potential performance enhancement, harmfulness to health, and violation of the spirit of sport. In considering the valid clinical uses of TH, the prevalence of TH use among young adults, the reason why some athletes seek to use TH, and the pathophysiology of sought-after and adverse effects of TH abuse, together with the challenges of detecting TH abuse, it can be concluded that, on the basis of present data, prohibition of TH in elite sport is neither justified nor feasible. Oxford University Press 2022-04-19 /pmc/articles/PMC9387720/ /pubmed/35438767 http://dx.doi.org/10.1210/clinem/dgac223 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Online Only Articles Gild, Matti L Stuart, Mark Clifton-Bligh, Roderick J Kinahan, Audrey Handelsman, David J Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge |
title | Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge |
title_full | Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge |
title_fullStr | Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge |
title_full_unstemmed | Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge |
title_short | Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge |
title_sort | thyroid hormone abuse in elite sports: the regulatory challenge |
topic | Online Only Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387720/ https://www.ncbi.nlm.nih.gov/pubmed/35438767 http://dx.doi.org/10.1210/clinem/dgac223 |
work_keys_str_mv | AT gildmattil thyroidhormoneabuseinelitesportstheregulatorychallenge AT stuartmark thyroidhormoneabuseinelitesportstheregulatorychallenge AT cliftonblighroderickj thyroidhormoneabuseinelitesportstheregulatorychallenge AT kinahanaudrey thyroidhormoneabuseinelitesportstheregulatorychallenge AT handelsmandavidj thyroidhormoneabuseinelitesportstheregulatorychallenge |